Atacand
Product Images NDC 54868-4413

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atacand (NDC 54868-4413). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atacand 16mg (30 tablet count bottle label)

ATACAND 16 mg film-coated tablets packaging label from Physicians Total Care, Inc. The label shows the product name ATACAND with the active ingredient candesartan cilexetil, dosage strength of 16 mg, and a count of 30 tablets per bottle. The label contains cautionary text regarding dispensing and instructions for storage and child safety.*

FDA Label Image

Image Of 32 mg Package Label (4612)

Packaging label for ATACAND 32 mg from Physicians Total Care, Inc. The label includes the lot number and an expiration date listed as 01/60. The manufacturer is noted as Astra Zeneca AB, Sodertalje, Sweden. A barcode and corresponding numerical code are printed below the product details.*

FDA Label Image

Image Of 8 mg Package Label (5489)

Label for ATACAND 8 MG, distributed by Physicians Total Care, Inc. It includes the lot number 0000, expiration date 01/60, and barcode. Manufacturing details show Pfizer Aktiebolag, Sweden.*

FDA Label Image

Image Of 4 mg Package Label (5591)

ATACAND 4MG label displaying dosage strength and lot number 0000. Manufactured by Astra Zeneca AG, Södertälje, Sweden. Distributed by Physicians Total Care, Inc., Tulsa, OK. Includes NDC 54868-5591-0 and an expiration date listed as 01/60, along with two barcodes.*

FDA Label Image

Figure 1 Graph (Atacand Atacand Image 02)

A forest plot chart comparing ATACAND to placebo across various patient subgroups categorized by age, sex, race, NYHA class, LVEF, medical history, and medication use. The chart shows hazard ratios with 95% confidence intervals indicating the relative effect of ATACAND versus placebo for each subgroup, with a reference line at 1.0 representing no difference.*

FDA Label Image

Structural Formula (Atacand Structuralformula)

Chemical structure diagram showing the molecular formula of the active ingredient in ATACAND, highlighting the site of ester hydrolysis within the chemical structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.